Israeli startup Lightico tops up Series B round; medtech firm Sweetch bags $20 mn

 Israeli startup Lightico tops up Series B round; medtech firm Sweetch bags $20 mn

Tel Aviv-based startup Lightico, which offers a digital e-signature and documentation collection platform for sectors like finance, auto, insurance and telecom, has raised $15 million in a follow-on Series B funding round led by Capital One Ventures.

Capital One, which has invested in the company for the second time in under a year, was joined by Poalim Capital Markets and other investors like lool Ventures, Crescendo Venture Partners and Mangrove Capital Partners, existing investors in Lightico.

With the latest funding, the company has raised a total Series B funding of $27 million. Oxx had led the original Series B round that was announced last November.

Overall, the startup has raised over $42 million since it started operations seven years ago.


Meanwhile, digital therapeutics company Sweetch, which has developed a hyper-personalised platform to deal with chronic ailments, has completed a $20 million Series A funding round, led by Entrée Capital.

Several other investors joined the round. These include Tal Capital, Dutch impact investor Noaber, Brazil-based Kortex Ventures and Israel’s FinTLV Ventures besides existing backers Philips, OurCrowd and Qure Ventures.

The eight-year-old startup said that it will use the money to expand its services globally and to develop artificial intelligence and emotional intelligence-based technology solutions.

Doron Dinstein, venture partner at Entrée Capital, said, “Sweetch’s digital therapeutic platform provides sustainable behaviour changes and has been shown to significantly impact people’s lives. We see the company radically improving the economics of healthcare.”

Aman Malik

The Capital Quest